H1B Report
H-1B sponsorCTFEIN 13-2686668Updated Jul 2026

BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

US H-1B Labor Condition Application activity for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.. Filed 395 disclosures between FY2010 and FY2026 from worksites with a CT headquarters indicator.

Total filings
9
Outside top-N · FY2026
Certified
100.0%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 93.9%, Cert-withdrawn 3.0%, Withdrawn 2.5%, Denied 0.5%
Outcome breakdown
OutcomeShare
Certified93.9%
Cert-withdrawn3.0%
Withdrawn2.5%
Denied0.5%
Certified93.9%
Cert-withdrawn3.0%
Withdrawn2.5%
Denied0.5%

Top occupations sponsored

SOC codes filed most by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY201026
FY201131
FY201225
FY201316
FY201425
FY201519
FY201625
FY201725
FY201823
FY201943
FY20208
FY202111
FY202215
FY20236
FY202442
FY202546
FY20269
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201026
FY201131
FY201225
FY201316
FY201425
FY201519
FY201625
FY201725
FY201823
FY201943
FY20208
FY202111
FY202215
FY20236
FY202442
FY202546
FY20269
Compare BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.